<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0213353.ref004">
 <label>4</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Vannice</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Chocarro</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Pfleiderer</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Bellah</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Ward</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Yoon</surname>
   <given-names>I-K</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia(R)) dossier</article-title>. 
  <source>Vaccine</source>. Netherlands; 
  <year>2017</year>;
  <volume>35</volume>: 
  <fpage>5731</fpage>â€“
  <lpage>5733</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.07.044</pub-id>
  <?supplied-pmid 28755835?>
  <pub-id pub-id-type="pmid">28755835</pub-id>
 </mixed-citation>
</ref>
